These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

918 related items for PubMed ID: 27234587

  • 1. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM, Al-Mekhlafi HM, Snounou G, Al-Jasari A, Sady H, Nasr NA, Lau YL, Surin J.
    Malar J; 2016 May 27; 15(1):295. PubMed ID: 27234587
    [Abstract] [Full Text] [Related]

  • 2. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA, Mahdy MA, Lim YA.
    Malar J; 2015 Dec 22; 14():516. PubMed ID: 26693691
    [Abstract] [Full Text] [Related]

  • 3. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM, Al-Mekhlafi HM, Atroosh WM, Ghzwani AH, Zain KA, Abdulhaq AA, Ghailan KY, Anwar AA, Eisa ZM.
    Malar J; 2020 Dec 02; 19(1):446. PubMed ID: 33267841
    [Abstract] [Full Text] [Related]

  • 4. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
    Mishra S, Bharti PK, Shukla MM, Ali NA, Kashyotia SS, Kumar A, Dhariwal AC, Singh N.
    Pathog Glob Health; 2017 Jun 02; 111(4):186-194. PubMed ID: 28549390
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A, Khattak AA, Nadeem MF, Fatima H, Mbambo G, Ouattara A, Adams M, Zeeshan N, Takala-Harrison S.
    Malar J; 2018 Dec 17; 17(1):471. PubMed ID: 30558587
    [Abstract] [Full Text] [Related]

  • 6. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
    Alareqi LMQ, Mahdy MAK, Lau YL, Fong MY, Abdul-Ghani R, Mahmud R.
    Acta Trop; 2016 Oct 17; 162():174-179. PubMed ID: 27343362
    [Abstract] [Full Text] [Related]

  • 7. High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
    Adeel AA, Elnour FA, Elmardi KA, Abd-Elmajid MB, Elhelo MM, Ali MS, Adam MA, Atta H, Zamani G, Warsame M, Barrette A, Mohammady HE, Nada RA.
    Malar J; 2016 May 21; 15(1):285. PubMed ID: 27209063
    [Abstract] [Full Text] [Related]

  • 8. Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP.
    Kolaczinski K, Leslie T, Ali I, Durrani N, Lee S, Barends M, Beshir K, Ord R, Hallett R, Rowland M.
    PLoS One; 2012 May 21; 7(1):e28957. PubMed ID: 22303437
    [Abstract] [Full Text] [Related]

  • 9. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
    Rana R, Khan N, Sandeepta S, Pati S, Das A, Bal M, Ranjit M.
    Malar J; 2022 Dec 24; 21(1):394. PubMed ID: 36566182
    [Abstract] [Full Text] [Related]

  • 10. Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles.
    Warsame M, Hassan AM, Barrette A, Jibril AM, Elmi HH, Arale AM, Mohammady HE, Nada RA, Amran JG, Muse A, Yusuf FE, Omar AS.
    Trop Med Int Health; 2015 Apr 24; 20(4):510-7. PubMed ID: 25583123
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
    Saha P, Guha SK, Das S, Mullick S, Ganguly S, Biswas A, Bera DK, Chattopadhyay G, Das M, Kundu PK, Ray K, Maji AK.
    Antimicrob Agents Chemother; 2012 May 24; 56(5):2511-7. PubMed ID: 22314538
    [Abstract] [Full Text] [Related]

  • 12. Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.
    Awab GR, Imwong M, Pukrittayakamee S, Alim F, Hanpithakpong W, Tarning J, Dondorp AM, Day NP, White NJ, Woodrow CJ.
    Malar J; 2016 Feb 25; 15():121. PubMed ID: 26917051
    [Abstract] [Full Text] [Related]

  • 13. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
    Jiang T, Chen J, Fu H, Wu K, Yao Y, Eyi JUM, Matesa RA, Obono MMO, Du W, Tan H, Lin M, Li J.
    Malar J; 2019 Mar 26; 18(1):101. PubMed ID: 30914041
    [Abstract] [Full Text] [Related]

  • 14. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
    Rouhani M, Zakeri S, Pirahmadi S, Raeisi A, Djadid ND.
    Infect Genet Evol; 2015 Apr 26; 31():183-9. PubMed ID: 25653131
    [Abstract] [Full Text] [Related]

  • 15. Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes.
    Shah NK, Schapira A, Juliano JJ, Srivastava B, MacDonald PD, Poole C, Anvikar A, Meshnick SR, Valecha N, Mishra N.
    Antimicrob Agents Chemother; 2013 Jul 26; 57(7):2948-54. PubMed ID: 23587943
    [Abstract] [Full Text] [Related]

  • 16. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
    Sitali L, Mwenda MC, Miller JM, Bridges DJ, Hawela MB, Hamainza B, Mudenda-Chilufya M, Chizema-Kawesha E, Daniels RF, Eisele TP, Nerland AH, Chipeta J, Lindtjorn B.
    Acta Trop; 2020 Dec 26; 212():105704. PubMed ID: 33002448
    [Abstract] [Full Text] [Related]

  • 17. Prevailing Plasmodium falciparum dihydrofolate reductase 108-asparagine in Hodeidah, Yemen: a questionable sulfadoxine-pyrimethamine partner within the artemisinin-based combination therapy.
    Abdul-Ghani R, Farag HF, Allam AF, Shawky SM.
    Acta Trop; 2014 Apr 26; 132():39-44. PubMed ID: 24406851
    [Abstract] [Full Text] [Related]

  • 18. Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.
    Gadalla NB, Abdallah TM, Atwal S, Sutherland CJ, Adam I.
    Malar J; 2013 Jul 19; 12():255. PubMed ID: 23870667
    [Abstract] [Full Text] [Related]

  • 19. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.
    Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T.
    PLoS One; 2007 Oct 10; 2(10):e1023. PubMed ID: 17925871
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
    Warsame M, Hassan AH, Hassan AM, Arale AM, Jibril AM, Mohamud SA, Barrette A, Muse AY, Yusuf FE, Nada RA, Amran JG.
    Trop Med Int Health; 2017 Apr 10; 22(4):415-422. PubMed ID: 28151566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.